1-Boc-4-[amino(phenyl)methyl]piperidine
![]() |
- $212 - $1600
- Product name: 1-Boc-4-[amino(phenyl)methyl]piperidine
- CAS: 612532-09-9
- MF: C17H26N2O2
- MW: 290.4
- EINECS:
- MDL Number:
- Synonyms:1-Boc-4-[amino(phenyl)methyl]piperidine;tert-Butyl 4-[amino(phenyl)methyl]piperidine-1-carboxylate;4-(Amino-phenyl-methyl)-piperidine-1-carboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 4-(aminophenylmethyl)-, 1,1-dimethylethyl ester
4 prices
Selected condition:
Brand
- A1 Biochem Labs
- ACHEMBLOCK
- Acrotein
- Chemenu
Package
- 250MG
- 1g
- 10g
- ManufacturerA1 Biochem Labs
- Product number6592907
- Product description1-Boc-4-[amino(phenyl)methyl]piperidine 95%
- Packaging10g
- Price$1600
- Updated2021-12-16
- Buy
- ManufacturerACHEMBLOCK
- Product numberP37086
- Product description1-Boc-4-[amino(phenyl)methyl]piperidine 95%
- Packaging250MG
- Price$340
- Updated2021-12-16
- Buy
- ManufacturerAcrotein
- Product numberP-1369
- Product description1-Boc-4-[amino(phenyl)methyl]piperidine 97%
- Packaging1g
- Price$550
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM336325
- Product description1-Boc-4-[amino(phenyl)methyl]piperidine 95%+
- Packaging250mg
- Price$212
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
A1 Biochem Labs | 6592907 | 1-Boc-4-[amino(phenyl)methyl]piperidine 95% | 10g | $1600 | 2021-12-16 | Buy |
ACHEMBLOCK | P37086 | 1-Boc-4-[amino(phenyl)methyl]piperidine 95% | 250MG | $340 | 2021-12-16 | Buy |
Acrotein | P-1369 | 1-Boc-4-[amino(phenyl)methyl]piperidine 97% | 1g | $550 | 2021-12-16 | Buy |
Chemenu | CM336325 | 1-Boc-4-[amino(phenyl)methyl]piperidine 95%+ | 250mg | $212 | 2021-12-16 | Buy |
Properties
Boiling point :401.5±18.0 °C(Predicted)
Density :1.085±0.06 g/cm3(Predicted)
pka :9.05±0.10(Predicted)
Density :1.085±0.06 g/cm3(Predicted)
pka :9.05±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|